Cross-reactive antibodies induced by a monovalent influenza B virus vaccine. Academic Article uri icon

Overview

abstract

  • Influenza viruses related to the markedly antigenically divergent strains B/Yamagata/16/88 and B/Victoria/2/87 are circulating in human populations. Adults develop cross-reacting antibodies against recent and earlier influenza B virus strains after vaccination with B/Yamagata/16/88, probably because of previous influenza B virus infections or immunizations. Vaccines containing B/Yamagata/16/88 should adequately protect adults against B/Victoria/2/87 infections.

publication date

  • July 1, 1991

Research

keywords

  • Influenza B virus
  • Influenza Vaccines

Identity

PubMed Central ID

  • PMC270149

Scopus Document Identifier

  • 0026052451

Digital Object Identifier (DOI)

  • 10.1128/jcm.29.7.1530-1532.1991

PubMed ID

  • 1885750

Additional Document Info

volume

  • 29

issue

  • 7